✦ LIBER ✦

Effects of an anti-interleuktn-6 (IL-6) murine monoclonal antibody in a patient with acute monoblastic leukemia

✍ Scribed by R. Bataille; X. G. Zhang; J. Wijdenes; J-F Schved; B. Klein

Book ID: 112963979
Publisher: Springer US
Year: 1993
Tongue: English
Weight: 327 KB
Volume: 10
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02989668

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative activity of Sant7 and anti-I

Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma

✍ Silvia Campo; Ottaviano Serlupi-Crescenzi; Brunilde Arseni; Stefania Rossi; Isab 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Safety and efficacy of tocilizumab, an a

Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis

✍ Tomoyuki Imagawa; Shumpei Yokota; Masaaki Mori; Takako Miyamae; Syuji Takei; Hir 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 368 KB

Role of interleukin-6 in a patient with

Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Eliz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Therapeutic benefit of blocking interleu

Therapeutic benefit of blocking interleukin-6 activity with an anti–interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial

✍ E. H. S. Choy; D. A. Isenberg; T. Garrood; S. Farrow; Y. Ioannou; H. Bird; N. Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

Successful treatment of an Epstein-Barr

Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody

✍ Bernard, F. ;Sarran, N. ;Margueritte, G. ;Barneon, G. ;Astruc, J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

Randomised phase II study of siltuximab

Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

✍ K. Fizazi; J.S. De Bono; A. Flechon; A. Heidenreich; E. Voog; N.B. Davis; Ming Q 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB